Responses
Neuropsychiatry
Research paper
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy
Compose a Response to This Article
Other responses
No responses have been published for this article.